<< Back
Price to Revenue (TTM)
This is the current Price divided by the Sales Per Share for the trailing twelve months. If there is a preliminary earnings announcement for an interim period that has recently ended, the revenue (sales) values from this announcement will be used in calculating the trailing twelve month revenue per share.
NASDAQ (US Dollar)
$72.13
 Stock is Down 0.31 (0.43%)
Data as of 11/20/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts
Gilead Sciences at Morgan Stanley Global Healthcare Conference

September 11, 2017 9:55 a.m. ET
Play
Gilead Sciences at Citi’s 12th Annual Biotech Conference

September 06, 2017 11:00 a.m. ET
Play
Gilead Sciences Business Update

August 28, 2017 8:00 a.m. ET
Play